JDSCX
Price
$34.83
Change
+$0.47 (+1.37%)
Updated
Dec 3 closing price
Net Assets
1.53B
VSCIX
Price
$124.07
Change
+$1.27 (+1.03%)
Updated
Dec 3 closing price
Net Assets
161.58B
Interact to see
Advertisement

JDSCX vs VSCIX

Header iconJDSCX vs VSCIX Comparison
Open Charts JDSCX vs VSCIXBanner chart's image
JPMorgan Small Cap Blend I
Price$34.83
Change+$0.47 (+1.37%)
VolumeN/A
Net Assets1.53B
Vanguard Small Cap Index I
Price$124.07
Change+$1.27 (+1.03%)
VolumeN/A
Net Assets161.58B
JDSCX vs VSCIX Comparison Chart in %
View a ticker or compare two or three
VS
JDSCX vs. VSCIX commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JDSCX is a Buy and VSCIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 162B vs. JDSCX (1.53B). VSCIX pays higher dividends than JDSCX: VSCIX (1.33) vs JDSCX (0.84). JDSCX was incepted earlier than VSCIX: JDSCX (27 years) vs VSCIX (28 years). JDSCX (1.02) is less costly to investors than VSCIX (0.04). JDSCX is a more actively managed with annual turnover of: 49.00 vs. VSCIX (13.00). JDSCX has a lower initial minimum investment than VSCIX: JDSCX (1000000) vs VSCIX (5000000). VSCIX annual gain was more profitable for investors over the last year : 0.21 vs. JDSCX (-2.21). VSCIX return over 5 years is better than : 39.61 vs. JDSCX (17.94).
JDSCXVSCIXJDSCX / VSCIX
Total Expense Ratio0.990.042,475%
Annual Report Gross Expense Ratio1.020.042,550%
Fund Existence27 years28 years-
Gain YTD5.1008.00464%
Front LoadN/AN/A-
Min. Initial Investment1000000500000020%
Min. Initial Investment IRAN/AN/A-
Net Assets1.53B162B1%
Annual Yield % from dividends0.841.3363%
Returns for 1 year-2.210.21-1,062%
Returns for 3 years23.5933.2571%
Returns for 5 years17.9439.6145%
Returns for 10 years36.08133.9727%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PLSH0.070.02
+33.09%
Panacea Life Sciences Holdings, Inc.
GRPOF0.77N/A
N/A
GRUPO TRAXION S A B DE C V
JSGCF12.00N/A
N/A
LIXIL Corp.
SBMFF0.87N/A
N/A
Sino Biopharmaceutical Ltd.
HAFG0.55N/A
N/A
Holistic Asset Finance Group Co., Ltd.